Approval Probability 71%
TA Base Rate26%
Adjusted LOA41%
ML RiskLOW_RISK
| NCT ID | Title | Phase | Status | Enrollment | Velocity | Design | Start | Completion | Last Updated | Sites | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|
| NCT00420953 | Relative Bioavailability of PM101 IV and Cordarone IV | PHASE1 | COMPLETED | - | — | — | Dec 18, 2006 | Apr 23, 2007 | Sep 8, 2017 | 1 | Canada |
| Name | Type | Description |
|---|---|---|
| Cordarone | DRUG | - |
Inclusion Criteria: * Be a healthy male or female 18 to 59 years of age, inclusive. Women of childbearing potential must be using a medically acceptable form of birth control for the duration of the trial and must have a negative serum pregnancy test at screening and upon check-in to the study faci...